Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Woodford Investment Management Ltd (CIK 1634557) reported $310.1M across 3 reported positions in its SEC 13F filing for 2019-09-30. Largest positions: TBPH ($221.1M, 71.30%), EVFM ($63.0M, 20.31%), AUTL ($26.0M, 8.39%), NCNA ($0, 0.00%), PRTA ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TBPH | THERAVANCE BIOPHARMA INC | $221.1M | 71.30% | 11.4M | Trimmed |
| 2 | EVFM | EVOFEM BIOSCIENCES INC | $63.0M | 20.31% | 12.5M | Trimmed |
| 3 | AUTL | AUTOLUS THERAPEUTICS PLC | $26.0M | 8.39% | 2.1M | Trimmed |
| 4 | NCNA | NUCANA PLC | $0 | 0.00% | 0 | Exited |
| 5 | PRTA | PROTHENA CORP PLC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2019-09-30